Terms: = Colorectal cancer AND BCL9L, BCL9-2, 283149, ENSG00000186174, DLNB11 AND Treatment
5 results:
1. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells.
Yadav P; Sharma P; Chetlangia N; Mayalagu P; Karunagaran D
Chem Biol Interact; 2022 Dec; 368():110224. PubMed ID: 36272469
[TBL] [Abstract] [Full Text] [Related]
2. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
3. Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells.
Mohammadi M; Salmasi Z; Hashemi M; Mosaffa F; Abnous K; Ramezani M
Int J Pharm; 2015 May; 485(1-2):50-60. PubMed ID: 25712164
[TBL] [Abstract] [Full Text] [Related]
4. MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of β-catenin in human colorectal cancer cells.
Subramanian M; Rao SR; Thacker P; Chatterjee S; Karunagaran D
J Cell Biochem; 2014 Nov; 115(11):1974-84. PubMed ID: 24913975
[TBL] [Abstract] [Full Text] [Related]
5. Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
Raghu D; Karunagaran D
J Nat Prod; 2014 May; 77(5):1130-4. PubMed ID: 24828199
[TBL] [Abstract] [Full Text] [Related]
